Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Bio-Works Technologies

3.04 SEK0.00 %19/11 14:58
Less than 1K followers

BIOWKS

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
0.00 %
-2.88 %
-5.30 %
-12.89 %
+16.03 %
+17.37 %
-31.87 %
-84.14 %
-64.62 %

Bio-Works Technologies operates in biotechnology. The company develops products that separate and purify molecules in the production of pharmaceuticals. The technology is based on chromatography, which is intended to handle the drug substance. Customers are found in the European market where the products are sold via distribution partners and to companies in the pharmaceutical industry, as well as research institutes and universities. The company was founded in 2006 and has its headquarters in Uppsala.

Read more
Market cap
306.96M SEK
Turnover
765.68 SEK
Revenue
62.5M
EBIT %
-28.03 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
19/2
2027

Annual report '26

All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release2026-11-17 08:00

Bio-Works Technologies AB: Valberedningen är utsedd inför årsstämman 2027

Bio-Works Technologies
Regulatory press release2026-10-30 08:00

Bio-Works Technologies AB: Bio-Works rapporterar tredje kvartalet 2026

Bio-Works Technologies
Regulatory press release2026-10-30 08:00

Bio-Works Technologies AB: Bio-Works reports third quarter 2026

Bio-Works Technologies

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
Followings and notifications on followed companies
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release2026-10-15 18:30

Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 8 of 11

Bio-Works Technologies
Regulatory press release2026-10-15 18:30

Bio-Works Technologies AB meddelar utfall från nyttjande av teckningsoptioner av serie TO 2. Nyttjandeperiod 8 av 11

Bio-Works Technologies
Regulatory press release2026-10-01 09:00

Today is the first day of the eighth exercise period for Bio-Works Technologies AB's warrants of series TO 2

Bio-Works Technologies
Regulatory press release2026-10-01 09:00

Idag inleds den åttonde nyttjandeperioden för Bio-Works Technologies AB:s teckningsoptioner av serie TO 2

Bio-Works Technologies
Regulatory press release2026-10-01 08:00

Bio-Works Technologies AB - Business Update third quarter 2026

Bio-Works Technologies
Regulatory press release2026-10-01 08:00

Bio-Works Technologies AB - Business Update tredje kvartalet 2026

Bio-Works Technologies
Regulatory press release2026-08-27 08:00

Bio-Works Technologies AB: Bio-Works tidligarelägger offentliggörandet av delårsraporten för tredjekvartalet 2026

Bio-Works Technologies
Regulatory press release2026-08-27 08:00

Bio-Works Technologies AB: Bio-Works brings forward the publication of its interim report for the third quarter of 2026

Bio-Works Technologies
Regulatory press release2026-08-25 08:57

Bio-Works Technologies AB: Bio-Works Secures New US Customer in the Development of Next-Generation Medicine

Bio-Works Technologies
Regulatory press release2026-08-25 08:57

Bio-Works Technologies AB: Bio-Works får ny amerikansk kund inom utveckling av nästa generations läkemedel

Bio-Works Technologies
Regulatory press release2026-08-21 08:00

Bio-Works Technologies AB: Bio-Works reports second quarter 2026

Bio-Works Technologies
Regulatory press release2026-08-21 08:00

Bio-Works Technologies AB: Bio-Works rapporterar andra kvartalet 2026

Bio-Works Technologies
Regulatory press release2026-08-18 09:00

Bio-Works Technologies AB utser Eva Lindskog till ny vd

Bio-Works Technologies
Regulatory press release2026-08-18 09:00

Bio-Works Technologies AB appoints Eva Lindskog as new CEO

Bio-Works Technologies
Regulatory press release2026-07-17 08:17

Bio-Works Technologies AB: Bio-Works Receives Order for 22,6 MSEK from Returning Customer

Bio-Works Technologies
Regulatory press release2026-07-17 08:17

Bio-Works Technologies AB: Bio-Works erhåller order på 22,6 Mkr från återkommande kund

Bio-Works Technologies
Regulatory press release2026-07-15 11:30

Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 7 of 11

Bio-Works Technologies